Restricted accessResearch articleFirst published online 2021-3
Association of apparent diffusion coefficient with Ki-67 proliferation index,progesterone-receptor status and various histopathological parameters,and its utility in predicting the high grade in meningiomas
Accurate preoperative determination of the histological grade and cellular proliferative potential of meningioma by non-invasive imaging is of paramount importance.
Purpose
To evaluate the utility of apparent diffusion coefficient (ADC) in determining the histological grade of meningioma, and to investigate the correlation of ADC with Ki-67 proliferation index (PI), progesterone receptor (PR) status, and a number of other histopathological parameters.
Material and Methods
Histopathologically confirmed 94 meningioma patients (72 low-grade, 22 high-grade) who had undergone preoperative diffusion-weighted imaging were retrospectively evaluated. ADC values were obtained by manually drawing the regions of interest (ROIs) within the solid components of the tumor. The relationship between ADC and Ki-67 values, PR status, and multiple histopathological parameters were investigated, and the ADC values of high-grade and low-grade meningiomas were compared. Independent sample t-test, Mann–Whitney U test, receiver operating characteristic, Pearson correlation, and multiple logistic regression analysis were used for statistical assessment.
Results
All ADC and rADC values were significantly lower in high-grade meningiomas than in low-grade meningiomas (all P < 0.05). ADC values showed significantly negative correlations with Ki-67 and mitotic index (P < 0.001 for each). Numerous ADC parameters were significantly lower in meningiomas demonstrating hypercellularity and necrosis features (P < 0.05). ADC values did not show a significant correlation with PR score (all P > 0.05).
Conclusion
ADC can be utilized as a reliable imaging biomarker for predicting the proliferative potential and histological grade in meningiomas.
RiemenschneiderMJPerryAReifenbergerG.Histological classification and molecular genetics of meningiomas. Lancet Neurol2006;
5:1045–1054.
2.
LouisDNPerryAReifenbergerG, et al.
The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol2016;
131:803–820.
3.
BambakidisNCNakajiP.Surgical treatment of meningiomas. Frontiers in bioscience2009;
1:587–599.
4.
TurgutMOzcanOEBenliK, et al.
Factors affecting morbidity and mortality following surgical intervention in patients with intracranial meningioma. Aust N Z J Surg1996;
66:144–150.
5.
MaierHOfnerDHittmairA, et al.
Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg1992;
77:616–623.
6.
VerheggenRFinkenstaedtMBockermannV, et al.
Atypical and malignant meningiomas: evaluation of different radiological criteria based on CT and MRI. Acta Neurochir Suppl1996;
65:66–69.
7.
HsuCCPaiCYKaoHW, et al.
Do aggressive imaging features correlate with advanced histopathological grade in meningiomas?J Clin Neurosci2010;
17:584–587.
8.
PalmaLCelliPFrancoC, et al.
Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg1997;
86:793–800.
9.
GallagherMJJenkinsonMDBrodbeltAR, et al.
WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?Clin Neurol Neurosurg2016;
141:117–121.
10.
GerdesJLiLSchlueterC, et al.
Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki-67.Am J Pathol1991;
138:867–873.
11.
TorpSHLindboeCFGronbergBH, et al.
Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. Clin Neuropathol2005;
24:170–174.
12.
BrunaJBrellMFerrerI, et al.
Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology2007;
27:114–120.
13.
BaskanOSilavGBolukbasiFH, et al.
Relation of apparent diffusion coefficient with Ki-67 proliferation index in meningiomas. Br J Radiol2016;
89:20140842.
14.
HsuDWEfirdJTHedley-WhyteEt.Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg1997;
86:113–120.
15.
RoserFNakamuraMBellinzonaM, et al.
The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol2004;
57:1033–1037.
16.
FewingsPEBattersbyRDTimperleyWR.Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?J Neurosurg2000;
92:401–405.
17.
WattsJBoxGGalvinA, et al.
Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging2014;
5:113–122.
18.
SchobSFrydrychowiczCGawlitzaM, et al.
Signal intensities in preoperative MRI do not reflect proliferative activity in meningioma. Transl Oncol2016;
9:274–279.
19.
HakyemezBYildirimNGokalpG, et al.
The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas. Neuroradiology2006;
48:513–520.
20.
YamasakiFKurisuKSatohK, et al.
Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology2005;
235:985–991.
21.
KonoKInoueYNakayamaK, et al.
The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol2001;
22:1081–1088.
22.
NagarVAYeJRNgWH, et al.
Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. AJNR Am J Neuroradiol2008;
29:1147–1152.
23.
PavlisaGRadosMPazaninL, et al.
Characteristics of typical and atypical meningiomas on ADC maps with respect to schwannomas. Clin Imaging2008;
32:22–27.
24.
SurovAGinatDTSanverdiE, et al.
Use of diffusion weighted imaing in differentiating between malignant and bening meningiomas. A multicenter analysis. World Neurosurg2016;
88:598–602.
25.
SurovAGottschlingSMawrinC, et al.
Diffusion-weighted imaging in meningioma: prediction of tumor grade and association with histopathological parameters. Transl Oncol2015;
8:517–523.
26.
SantelliLRamondoGDella PuppaA, et al.
Diffusion-weighted imaging does not predict histological grade in meningiomas. Acta Neurochir (Wien) 2010;
152:1315–1319.
27.
SanverdiSEOzgenBOguzKK, et al.
Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas?Eur J Radiol2012;
81:2389–2395.
28.
ZikouAAlexiouGAGoussiaA, et al.
The role of diffusion tensor imaging and dynamic susceptibility perfusion MRI in the evaluation of meningioma and subtype. Clin Neurol Neurosurg2016;
146:109–115.
29.
SurovAHamerlaGMeyerHJ, et al.
Whole lesion histogram analysis of meningiomas derived from ADC values. Correlation with several cellularity parameters, proliferation index KI 67, nucleic content, and membrane permeability. Magn Reson Imaging2018;
51:158–162.
30.
GihrGAHorvath-RizeaDGarnovN, et al.
Diffusion profilling via a histogram approach distinguishes low-grade from high-grade meningiomas, can reflect the respective proliferative potential and progesterone receptor status. Mol Imaging Biol2018;
20:632–640.
31.
ZhangSChiangGCKnappJM, et al. Grading meningiomas utilizing multiparametric MRI with the inclusion of susceptibility weighted imaging and quantitative susceptibility mapping. J Neuroradiol. Epub ahead of print 25 May 2019. DOI: 10.1016/j.neurad.2019.05.002
32.
HameralGMeyerHJSchobS, et al.
Comparison of machine learning classifiers for differentiation of grade 1 from higher gradings in meningioma: A multicenter radiomics study. Magn Reson Imaging2019;
63:244–249.
33.
ZhuYManCGongL, et al.
A deep learning radiomics model for preoperative grading in meningioma. Eur J Radiol2019;
116:128–134.
34.
LuYLiuLLuanS, et al.
The diagnostic value of texture analysis in predicting WHO grades of meningiomas based on ADC maps: an attempt usging decision tree and decision forest. Eur Radiol2019;
29:1318–1328.
35.
SurovACaysaHWienkeA, et al.
Correlation between different ADC fractions, cell count, Ki-67, total nucleic areas and average nucleic areas in meningothelial meningiomas. Anticancer Res2015;
35:6841–6846.
36.
SchobSSurovAWienkeA, et al.
Correlation between aquaporin 4 expression and different DWI parameters in grade I meningioma. Mol Imaging Biol2016;
19:138–142.
37.
ChenLLiuMBaoJ, et al.
The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis. PLoS One2013;
8:e79008.
38.
TangYDundamadappaSKThangasamyS, et al.
Correlation of apparent diffusion coefficient with Ki-67 porliferation index in grading meningioma. AJR Am J Roentgenol2014;
202:1303–1308.
39.
SurovAMeyerHJWienkeA.Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget2017;
8:59492–59499.
40.
GihrGAHorvath-RizeaDKohlhof-MeineckeP, et al.
Histogram profiling of post-contrast T1-Weighted MRI gives Valuable Insights into tumor biology and enables prediction of Growth Kinetics and prognosis in meningiomas. Transl Oncol2018;
11:957–961.
41.
MeyerHJPazaitisNSurovA.ADC histogram analysis of muscle lymphoma-correlation with histopathology in a rare entity. Br J Radiol2018;
91:20180291.
42.
SchobSMeyerJGawlitzaM, et al.
Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma. PLoS One2016;
11:e0161386.
43.
MeyerHJLeifelsLHamerlaG, et al.
Histogram analysis parameters derived from conventional T1- and T2-weighted images can predict different histopathological features including expression of Ki-67, EGFR, VEGF, HIF-1alpha, and p53 and cell count in head and neck squamous cell carcinoma. Mol Imaging Biol2019;
21:740–746.
44.
MeyerHJHohnASurovA.Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study. Oncotarget2018;
9:18510–18517.
45.
SchobSVoigtPBureL, et al.
Diffusion-weighted imaging using a readout-segmented, multishot EPI sequence at 3T distinguishes between morphologically differentiated and undifferentiated subtypes of thyroid carcinoma – A preliminary study. Transl Oncol2016;
9:403–410.
46.
MeyerHJGundermannPHohnAK, et al.
Associations between whole tumor histogram analysis parameters derived from ADC maps and expression of EGFR, VEGF, Hif 1-alpha, Her-2 and Histone 3 in uterine cervical cancer. Magn Reson Imaging2019;
57:68–74.
47.
FatimaZMotosugiUWaqarAB, et al.
Associations among q-space MRI, diffusion-weighted MRI and histopathological parameters in meningiomas. Eur Radiol2013;
23:2258–2263.
48.
GinatDTManglaRYeaneyG, et al.
Correlation of diffusion and perfusion MRI with Ki-67 in high-grade meningiomas. AJR Am J Roentgenol2010;
195:1391–1395.
49.
KonstantinidouAEKorkolopoulouPMaheraH, et al.
Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology2003;
43:280–290.
50.
BrandisAMirzaiSTatagibaM, et al.
Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery1993;
33:212–217.
51.
AslanKGunbeyHPTomakL, et al.
The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between low- and high-grade meningioma. Br J Radiol2018;
91:20180088.
52.
LinBJChouKNKaoHW, et al.
Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg2014;
121:1201–1208.
53.
LiXMiaoYHanL, et al.
Meningioma grading using conventional MRI histogram analysis based on 3D tumor measurement. Eur J Radiol2019;
110:45–53.
54.
KohDMColinsDJ.Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol2007;
188:1622–1635.
